发明申请
US20120040969A1 N-PHENYL-(PIPERAZINYL OR HOMOPIPERAZINYL)-BENZENESULFONAMIDE OR BENZENESULFONYL-PHENYL-(PIPERAZINE OR HOMOPIPERAZINE) COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR
有权
N-苯基 - （哌嗪酰基或对羟基苯甲酰基） - 苯磺酰胺或苯并呋喃基 - 苯基 - （哌嗪或或邻苯二酚）化合物，适用于治疗调节SEROTONIN 5-HT6受体的病症
- 专利标题： N-PHENYL-(PIPERAZINYL OR HOMOPIPERAZINYL)-BENZENESULFONAMIDE OR BENZENESULFONYL-PHENYL-(PIPERAZINE OR HOMOPIPERAZINE) COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR
- 专利标题（中）： N-苯基 - （哌嗪酰基或对羟基苯甲酰基） - 苯磺酰胺或苯并呋喃基 - 苯基 - （哌嗪或或邻苯二酚）化合物，适用于治疗调节SEROTONIN 5-HT6受体的病症
-
申请号： US13284204申请日： 2011-10-28
-
公开(公告)号： US20120040969A1公开(公告)日： 2012-02-16
- 发明人: Andreas Haupt , Frauke Pohlki , Karla Drescher , Karsten Wicke , Liliane Unger , Ana-Lucia Relo , Anton Bespalov , Barbara Vogg , Gisela Backfisch , Juergen Delzer , Min Zhang , Yanbin Lao
- 申请人： Andreas Haupt , Frauke Pohlki , Karla Drescher , Karsten Wicke , Liliane Unger , Ana-Lucia Relo , Anton Bespalov , Barbara Vogg , Gisela Backfisch , Juergen Delzer , Min Zhang , Yanbin Lao
- 申请人地址： US IL Abbott Park DE Wiesbaden
- 专利权人： Abbott Laboratories,Abbott GmbH & Co. KG
- 当前专利权人： Abbott Laboratories,Abbott GmbH & Co. KG
- 当前专利权人地址： US IL Abbott Park DE Wiesbaden
- 主分类号： A61K31/551
- IPC分类号： A61K31/551 ; C07D241/04 ; A61P25/28 ; A61P25/00 ; A61P25/18 ; C07D243/08 ; A61K31/4965
摘要：
The present invention relates to N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds, pharmaceutical compositions containing them, and their use in therapy. The compounds possess valuable therapeutic properties and are particularly suitable for treating diseases that respond to modulation of the serotonin 5-HT6 receptor.
公开/授权文献
信息查询
